Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 7 subfamily E member 109 pseudogene (OR7E109P) is annotated as a pseudogene in the human genome, meaning it resembles protein-coding olfactory receptor genes but does not produce a functional protein. OR7E109P is related to other olfactory receptor pseudogenes and is not considered an active receptor, enzyme, or therapeutic molecular target. Like other olfactory receptor pseudogenes, it may have a regulatory RNA function, potentially acting as a competitive endogenous RNA to modulate GPCR signaling through microRNA sequestration. There is no evidence for direct involvement in smell perception, receptor function, or interaction with drugs, and it is not known as a biomarker or therapeutic target. The gene's transcript is noncoding, and its biological relevance is limited to possible RNA-level regulatory effects, without known disease associations or safety concerns.
None known; no known drugs target this pseudogene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 7 subfamily E member 109 pseudogene (OR7E109P).